Company News
Hybio and Dr. Reddy's Advance Global Peptide API Collaboration
A strategic cooperation term sheet creates a framework for peptide API development, supply, and broader global collaboration.
Hybio Pharmaceutical and Dr. Reddy's Laboratories have signed a non-binding strategic cooperation term sheet covering peptide active pharmaceutical ingredients and related formulations.
The framework builds on complementary strengths in peptide technology, industrialization, regulatory registration, and international market access.
Complementary global capabilities
The parties will explore cooperation across multiple peptide API programs, with Hybio supporting development and supply for selected formulation projects.
Future discussions may also extend to generic medicines, oligonucleotides, and other therapeutic areas.
